GEMRALEDGE
About Gemral & research index

ELV Insider Buying & Government Contracts (2026)

Quick Facts & Defense Contracting Direct Answers

How much does Elevance Health, Inc. receive in federal government contracts?

Elevance Health, Inc. has been awarded over $53.5M in tracked prime federal obligations across 1 awarding agencies spanning 2 active contracts, as recorded in official FPDS and USAspending data.

Which congressional lawmakers trade Elevance Health, Inc. (ELV) stock?

Public Periodic Transaction Reports (PTR) under the STOCK Act record transactions in Elevance Health, Inc. (ELV) by members of Congress including Ro Khanna, Jared Moskowitz, Michael T Mccaul.

How are federal defense contracts mapped to Elevance Health, Inc. on Gemral Edge?

Gemral Edge programmatically reconciles prime award obligations from SAM.gov, USAspending, and FPDS through corporate parent CAGE and UEI hierarchies directly to ticker ELV.

Major Federal & Defense Procurement Contracts

Recent prime contract obligations, delivery orders, and modifications awarded to Elevance Health, Inc.:

Action DateAwarding AgencyObligated AmountAward IDContract Description
2026-10-06Department of Health and Human Services$52.1MCONT_AWD_HHSM500201700002C_7530_-NONE-_-NONE-NEXT GENERATION DESKTOP IGF::OT::IGF
2026-10-06Department of Health and Human Services$1.4MCONT_AWD_75FCMC25FJ091_7530_47QTCA24D00EF_4732HITECH PAYMENT FILE DEVELOPMENT CONTRACTOR. SEE LIST OF ATTACHMENTS: BASE

Elevance Health, Inc. (ELV) is an active recipient of U.S. federal and defense procurement awards. According to federal procurement records and obligation filings, the company has been awarded 2 prime federal contracts and delivery orders totaling approximately $53.5M across 1 federal awarding agencies, with the most recent award action registered on 2026-10-06.

Federal contracts represent substantial multi-year revenue visibility for prime contractors and defense suppliers. Gemral Edge continuously reconciles federal award obligations from the Federal Procurement Data System (FPDS) and USAspending with congressional disclosures, tracking capital flow from policy authorization through corporate execution.

Verified from official public disclosure — record ELV-CONGRESS-DISCLOSURE

Updated: · Author: Jennie Chu · Reviewed by: Gemral Research Desk · Editorial Policy

Unified Ticker Intelligence Dossier (ELV)

Synthesis: Mã ELV ghi nhận dữ liệu hoạt động tổng hợp qua các kênh công quyền và dòng tiền.

Temporal Context: Ghi nhận sự kiện và luồng thông tin mới trong 365 ngày qua đối với ELV.

Data Coverage & Verification: Overall coverage score: 67% across 6 pillars (Government, Policy, Flow, Management, Catalysts, Historical). Verified by 3 independent statutory data sources.

Congressional Stock Trading Activity in ELV

Disclosed stock purchases and sales by members of Congress and spouses involving Elevance Health, Inc. securities under the STOCK Act:

LawmakerParty-StateChamberTransaction DateActionDisclosed RangeEst. Return
Ro KhannaD-CAHOUSE2026-07-20SELL$1K – $15K+16.5%
Alan ArmstrongR-OKSENATE2026-03-27BUY$1K – $15K+55.5%
Ro KhannaD-CAHOUSE2026-05-15BUY$1K – $15K+13.4%
Ro KhannaD-CAHOUSE2026-04-13BUY$1K – $15K+40.9%
Ro KhannaD-CAHOUSE2026-03-30SELL$1K – $15K+56.4%
Ro KhannaD-CAHOUSE2026-02-24BUY$15K – $50K+36.1%
Ro KhannaD-CAHOUSE2026-02-17BUY$1K – $15K+29.1%
Ro KhannaD-CAHOUSE2026-01-29SELL$1K – $15K+28.3%
Ro KhannaD-CAHOUSE2026-01-23BUY$1K – $15K+20.0%
Markwayne MullinR-OKSENATE2025-12-29BUY$15K – $50K+27.8%
Ro KhannaD-CAHOUSE2025-11-03SELL$1K – $15K+42.2%
Michael T. McCaulR-TXHOUSE2025-10-27SELL$15K – $50K+30.0%
Ro KhannaD-CAHOUSE2025-09-29BUY$1K – $15K+39.3%
Ro KhannaD-CAHOUSE2025-09-05BUY$1K – $15K+42.0%
Lisa C. McClainR-MIHOUSE2025-08-13SELL$1K – $15K+51.2%

ELV insider buying and selling over the past year

Over the past year Elevance Health, Inc. insiders filed 3 open-market Form 4 trades — 1 purchases worth $869.5K and 2 sales worth $918.1K — which makes them net sellers by $48.6K.

None of the 2 sales were flagged as Rule 10b5-1 plan trades, meaning each one was a discretionary decision at the time of filing. Activity clustered in 2026-03 (3 trades); the latest filing in this window is dated 2026-03-12. The average open-market sale price was $284.94; the last close of $428.26 is 50.3% above that level, so sellers left upside on the table. The single largest trade was a sale of 3,196 shares worth $910.6K on 2026-03-06. Since the most recent filing the stock has moved +48.8%, from $287.89. Insiders paid an average of $289.84 per share for their open-market purchases; against the last close of $428.26 that cost basis is sitting on a gain at +47.8%.

Largest ELV open-market insider trades, past year (SEC Form 4)
Trade dateTypeSharesPriceValueFiling
2026-03-06Sell3,196$284.92$910.6K0001887908-26-000005
2026-03-05Buy3,000$289.84$869.5K0001191508-26-000002
2026-03-12Sell26$287.50$7.5K0001438226-26-000007

Where ELV trades relative to its one-year range

Elevance Health, Inc. closed at $428.26 on 2026-10-16, inside a one-year range of $280.74 to $428.43. That puts the stock near the top of its range, at 99.9% of the distance from low to high. Over one year the share price moved +23.0%, and over roughly three months +14.8%. Average daily volume over the last month was about 1,265,431 shares.

Across 57 companies in the same SEC industry group (SIC 63) with a full year of prices in Gemral Edge, the median one-year return was +10.0%. ELV is ahead of that median and beat 70% of that peer group on this measure.

Members of Congress who traded ELV

STOCK Act disclosures show 47 trades in ELV by 15 members of Congress over five years (27 purchases, 20 sales), most recently on 2026-07-20. The most active traders were Ro Khanna (D-CA), 17 trades; Jared Moskowitz (D-FL), 6 trades; Michael T. McCaul (R-TX), 4 trades; Gilbert Ray Cisneros, Jr. (D-CA), 3 trades; Lisa C. McClain (R-MI), 3 trades.

By party the trades split 30 by Democrats, 17 by Republicans; by chamber, 44 from the House, 3 from the Senate.

Elevance Health, Inc. federal contract exposure

Federal procurement records resolve 2 prime award actions to Elevance Health, Inc., worth $53.50M across 1 agencies. Department of Health and Human Services accounts for 100.0% of that value ($53.50M), so revenue from this channel depends heavily on one buyer.

Compare ELV with indexed peers from the same industry group

These peers have full Gemral Edge dossiers and the closest one-year price move to ELV:

  • ALL one-year return +27.2%
  • ACGL one-year return +17.4%
  • MET one-year return +29.4%
  • PRU one-year return +16.1%
  • UNH one-year return +12.5%

Sources and method

Every figure above is computed from public filings stored in Gemral Edge, not estimated. Insider figures count only open-market purchases and sales reported on SEC Form 4; option exercises, grants and gifts are excluded because they do not reflect a decision to buy or sell at market prices.

  • SEC EDGAR Form 4 (edge_insider_trades, codes P/S open-market only) — as of 2026-03-12
  • edge_prices_eod (end-of-day close) — as of 2026-10-16
  • House PTR / Senate eFD disclosures (edge_congress_trades) — as of 2026-07-20
  • FPDS / USAspending (edge_contracts, tier-1 resolved) — as of 2026-10-06

ELV data questions

Are ELV insiders buying or selling stock?

Over the past year Elevance Health, Inc. insiders filed 3 open-market Form 4 trades — 1 purchases worth $869.5K and 2 sales worth $918.1K — which makes them net sellers by $48.6K.

What is the one-year price range for ELV?

Based on end-of-day closes through 2026-10-16, ELV traded between $280.74 and $428.43, last closing at $428.26.

Has any member of Congress traded ELV stock?

Yes. 15 members disclosed 47 trades in ELV over five years; the most recent disclosed trade date is 2026-07-20.

Which congressional committees and active lawmakers are linked to this sector?

Disclosed lawmakers and congressional committees holding policy jurisdiction, defense appropriations oversight, or direct capital exposure in ELV:

Latest Real-Time Intelligence & Breaking Events

Live contract obligations, SEC filings, and procurement intelligence for Elevance Health, Inc. are monitored 24/7 on Gemral Edge Breaking News and Defense Radar.

Federal Contracting Dynamics & Government Revenue Exposure

Government contracting for defense and enterprise infrastructure follows strict Federal Acquisition Regulation (FAR) guidelines, often spanning multi-year base periods with optional extension years. Monitoring prime contractor award velocity provides institutional investors and market participants with un-lagged visibility into backlog expansion, agency budget priorities, and defense authorization funding flows.

Furthermore, when members of congressional defense, intelligence, or appropriations committees disclose trading activity in major federal contractors such as Elevance Health, Inc., cross-referencing contract award timelines with legislative disclosures highlights important intersections of public policy and corporate performance.

Frequently asked questions

How much does Elevance Health, Inc. receive in federal government contracts?

Elevance Health, Inc. holds over $53.5M in tracked federal obligations across 1 public agencies, providing multi-year revenue visibility across defense and civilian procurement budgets.

Which congressional lawmakers trade Elevance Health, Inc. (ELV) stock?

Elevance Health, Inc. (ELV) stock transactions have been disclosed by members of Congress including Ro Khanna, Jared Moskowitz, Michael T Mccaul, Gilbert Ray Cisneros Jr. Disclosures filed under the STOCK Act detail execution dates, asset classes, and statutory valuation ranges.

How are federal defense contracts resolved to Elevance Health, Inc.?

Gemral Edge maps prime award notices from the Federal Procurement Data System (FPDS) and USAspending through Ultimate Parent CAGE and UEI corporate hierarchies directly to parent ticker ELV.

What technology stack signals are detected for Elevance Health, Inc.?

Active talent hiring requisitions and engineering role profiles are continuously monitored across public corporate job postings to track enterprise software adoption and technology migration patterns.

Data intelligence from public filings — not investment advice.

Explore Gemral Edge

Latest Gemral Edge stories →

More Gemral Edge research

Risk Disclaimer

Trading and investing in digital assets, financial instruments, and predictive events involve substantial risk of loss and are not suitable for every investor. The predictive intelligence, probability distributions, historical precedents, and scenario modeling presented on this page are compiled for informational and research purposes only and do not constitute financial, investment, legal, or tax advice. Past performance and statistical precedents do not guarantee future outcomes. Always conduct independent due diligence before committing capital.